CPDA-1 209 mg/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical use. Learn more about its applications and benefits.

Strength

209 mg/70mL

Pack Size

70 mL in 1 BAG (0942-6308-02)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 209 mg/70mL is primarily used to prevent blood clotting during storage. This anticoagulant solution is often employed in medical settings to maintain the viability of blood components for transfusions. The solution's formulation helps extend the shelf life of stored blood, ensuring it remains usable for longer periods. Healthcare professionals may use CPDA-1 209 mg/70mL to prepare blood for various medical procedures.

Side Effects

When administered intravenously, CPDA-1 209 mg/70mL works by binding calcium ions, which are essential for the clotting process. This action helps keep the blood in a liquid state, preventing it from coagulating. The solution's components also provide nutrients that support the metabolic needs of blood cells during storage. Users may notice that the blood remains fluid and viable for an extended period.

Precautions & Warnings

CPDA-1 209 mg/70mL should be handled with care to avoid contamination. It is important to follow proper storage guidelines to maintain the solution's efficacy. Users should ensure that the solution is administered by trained healthcare professionals to minimize the risk of adverse effects. Always check the packaging for any specific instructions or warnings.

Avoid Interactions

CPDA-1 209 mg/70mL may interact with certain medications or substances that affect blood clotting. It is advisable to consult with a healthcare provider before using this solution, especially if you are taking other anticoagulants or blood thinners. Additionally, the solution should not be mixed with other medications without professional guidance to avoid potential interactions.

Frequently Asked Questions

CPDA-1 209 mg/70mL is used to prevent blood clotting during storage, ensuring the viability of blood components for transfusions.

CPDA-1 209 mg/70mL binds calcium ions, which are necessary for blood clotting, keeping the blood in a liquid state.

CPDA-1 209 mg/70mL should be handled by trained healthcare professionals to ensure proper administration and minimize risks.

CPDA-1 209 mg/70mL should not be mixed with other medications without consulting a healthcare provider to avoid potential interactions.

CPDA-1 209 mg/70mL should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.